Видео ютуба по тегу Context Therapeutics

Context Therapeutics' Big Stock Sale Play: My Insider Look
Context Therapeutics' Big Stock Sale Play: My Insider Look
Context Therapeutics highlights data on ONA-XR and CLDN6 at AACR 2022. With Martin Lehr.
Context Therapeutics highlights data on ONA-XR and CLDN6 at AACR 2022. With Martin Lehr.
Context Therapeutics - Precision Oncology - $CNTX
Context Therapeutics - Precision Oncology - $CNTX
Context Therapeutics; Meet CEO Martin Lehr
Context Therapeutics; Meet CEO Martin Lehr
Context Therapeutics; Recapping 2022 & What to Look Forward to in 2023
Context Therapeutics; Recapping 2022 & What to Look Forward to in 2023
Context Therapeutics; Answering Viewer's Questions About the Company
Context Therapeutics; Answering Viewer's Questions About the Company
Up 93% This Year! Is Context Therapeutics (CNTX) the Next Big Runner? CNTX STOCK PODCAST TODAY PRICE
Up 93% This Year! Is Context Therapeutics (CNTX) the Next Big Runner? CNTX STOCK PODCAST TODAY PRICE
Context Therapeutics releases corporate priorities and pipeline milestones for 2023
Context Therapeutics releases corporate priorities and pipeline milestones for 2023
Context Therapeutics; What CEO Martin Lehr Looks for in Successful Bio-tech Companies
Context Therapeutics; What CEO Martin Lehr Looks for in Successful Bio-tech Companies
Big Biz Show interview with Context Therapeutics CEO Martin Lehr - Dec. 13, 2022
Big Biz Show interview with Context Therapeutics CEO Martin Lehr - Dec. 13, 2022
Martin Lehr, CEO/Co-Founder of Context Therapeutics Inc., talks about cancer treatments.
Martin Lehr, CEO/Co-Founder of Context Therapeutics Inc., talks about cancer treatments.
Gynecological Cancer Therapies With Context Therapeutics' Martin Lehr
Gynecological Cancer Therapies With Context Therapeutics' Martin Lehr
Context Therapeutics; Answering More Viewer's Questions
Context Therapeutics; Answering More Viewer's Questions
Colliers LabNotes / Marty Lehr of Context Therapeutics
Colliers LabNotes / Marty Lehr of Context Therapeutics
Martin Lehr, CEO/ Co-Founder of Context Therapeutics talks about their stages of drug development.
Martin Lehr, CEO/ Co-Founder of Context Therapeutics talks about their stages of drug development.
Context Therapeutics webinar: Claudin 6 x CD3 bispecific antibody data update
Context Therapeutics webinar: Claudin 6 x CD3 bispecific antibody data update
The Entrepreneur Behind a Cure: Martin Lehr’s Mission to Outsmart Cancer
The Entrepreneur Behind a Cure: Martin Lehr’s Mission to Outsmart Cancer
Context Therapeutics releases CTIM-76 Claudin 6 Therapeutic Antibody updates
Context Therapeutics releases CTIM-76 Claudin 6 Therapeutic Antibody updates